-+ 0.00%
-+ 0.00%
-+ 0.00%

ARS Pharmaceuticals files Form 3 for President Donn Casale, reporting no beneficial ownership

PUBT·06/01/2026 20:43:05
Listen to the news
ARS Pharmaceuticals files Form 3 for President Donn Casale, reporting no beneficial ownership
  • ARS Pharmaceuticals President Donn Casale filed an initial Form 3 beneficial ownership statement on June 1, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ARS Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002135296-26-000005), on June 01, 2026, and is solely responsible for the information contained therein.